Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| RAYZEBIO INCCOM | 5,158,162 | 5,158,162 | 0 | $114.51M | $320.68M | 48.06% | +$206.17M |
| ALX Oncology Holdings Inc.COM(ALXO) | 9,699,925 | 9,699,925 | 0 | $46.56M | $144.43M | 21.65% | +$97.87M |
| PHARVARIS N VCOM COM | 4,264,672 | 4,919,504 | +654,832 | $89.00M | $137.99M | 20.68% | +$48.99M |
| Harmony Biosciences Holdings, Inc.COM(HRMY) | 1,035,396 | 1,035,396 | 0 | $33.93M | $33.44M | 5.01% | -$486.6K |
| ACELYRIN INCCOM | 3,852,470 | 3,852,470 | 0 | $39.18M | $28.74M | 4.31% | -$10.44M |
| ELEVATION ONCOLOGY INCCOM | 2,914,255 | 2,914,255 | 0 | $1.93M | $1.56M | 0.23% | -$366.0K |
| IMPEL PHARMACEUTICALS INCCOM | 2,759,791 | 2,759,791 | 0 | $1.19M | $340.8K | 0.05% | -$845.9K |
| VENTYX BIOSCIENCES INCCOM | 758,800 | 0 | -758,800 | $26.35M | $0 | — | -$26.35M |